Found: 16
Select item for more details and to access through your institution.
Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines.
- Published in:
- Cancer & Metabolism, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40170-021-00272-7
- By:
- Publication type:
- Article
Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature.
- Published in:
- Netherlands Heart Journal, 2022, v. 30, n. 6, p. 295, doi. 10.1007/s12471-021-01655-7
- By:
- Publication type:
- Article
Complications affecting preterm neonates from 1991 to 2006: what have we gained?
- Published in:
- Acta Paediatrica, 2010, v. 99, n. 3, p. 354, doi. 10.1111/j.1651-2227.2009.01648.x
- By:
- Publication type:
- Article
Systemic therapy timing and use in patients with advanced melanoma at the end of life: A retrospective cohort study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 4, p. 584, doi. 10.1111/1346-8138.17061
- By:
- Publication type:
- Article
Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?
- Published in:
- Acta Paediatrica, 2003, v. 92, n. 7, p. 827, doi. 10.1111/j.1651-2227.2003.tb02541.x
- By:
- Publication type:
- Article
Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non‐high‐grade serous ovarian carcinomas.
- Published in:
- Journal of Pathology, 2024, v. 262, n. 2, p. 137, doi. 10.1002/path.6218
- By:
- Publication type:
- Article
Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12336-0
- By:
- Publication type:
- Article
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2006, v. 24, n. 9, p. 1341, doi. 10.1111/j.1365-2036.2006.03127.x
- By:
- Publication type:
- Article
Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 4, p. 321, doi. 10.1111/j.1365-2036.2005.02335.x
- By:
- Publication type:
- Article
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02715-z
- By:
- Publication type:
- Article
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02715-z
- By:
- Publication type:
- Article
The Summer School Oncology Groningen: Improving a Successful International Course by Refining the Old, Maintaining What's Good.
- Published in:
- Journal of Cancer Education, 2022, v. 37, n. 4, p. 1228, doi. 10.1007/s13187-020-01944-6
- By:
- Publication type:
- Article
Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 5, p. 1092, doi. 10.1093/carcin/bgt484
- By:
- Publication type:
- Article